The Chinese character “ren” means people and humanity. RenBio was founded on the principle that the remarkable medical benefits of antibody therapeutics should be available to everyone.
Antibody therapeutics provide an overwhelming benefit for human health, but major obstacles in their administration, efficacy, duration, and cost limit their more widespread use. We have reimagined the way antibody therapeutics can be produced and delivered to overcome these obstacles.
Our delivery platform takes advantage of the body’s ability to produce any given antibody when provided with the precise set of genetic instructions. These instructions, encoded in DNA, are biological blueprints.
Using RenBio’s Make Your Own (MYO) technology, antibody encoding “bioblueprints” are delivered by a modified intramuscular injection and then read by muscle cells to produce disease-fighting antibodies in the patient’s own body.
RenBio was co-founded by Drs. David Ho and Yaoxing Huang, visionary scientists affiliated with the Aaron Diamond AIDS Research Center in New York City. Since opening our doors in 2016, we have rapidly grown into a diverse, multidisciplinary team, with expertise spanning a range of biological and engineering fields. Our approach leverages the breadth of our collective knowledge to develop a true platform technology with the ability to deliver antibodies for the prevention and treatment of multiple diseases.
If you have any questions or comments, or if you are interested in joining our team, you can send us a message using the form below. We are always seeking exceptional talent; if you are a creative, highly motivated individual interested in working in a fast-paced, multidisciplinary, collaborative environment, tell us about yourself and why you are interested in joining us!
430 East 29th Street, Suite 600, New York, NY 10016
Office
430 East 29th Street
Suite 600
New York, NY 10016
